Fifth Third Bancorp
GDRX icon

Fifth Third Bancorp’s GoodRx Holdings GDRX Stock Holding History

Fifth Third Bancorp’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$4.98K – 2707
2025
Q2 		$4.98K Buy
+1,000
New +$4.34K ﹤0.01% 2193

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fifth Third Bancorp's GDRX Position: Q3 2025 in Review

Fifth Third Bancorp sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 1,000 shares — an estimated $4.98K sold.

Fifth Third Bancorp first reported a position in GDRX in Q2 2025 and held it in 1 quarter. The position peaked at $4.98K in Q2 2025. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Fifth Third Bancorp reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,000 GoodRx Holdings shares in Q3 2025, an estimated $4.98K.
  • Fifth Third Bancorp first reported a position in GoodRx Holdings in Q2 2025 and held it in 1 quarter.
  • Fifth Third Bancorp's GoodRx Holdings position peaked at $4.98K in Q2 2025.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.